|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
276 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | ACEI inhibitors and ARBs do not increase severity of COVID-19 |
|
1802 | 1 |
p. 5 |
article |
||
| 2 | Acetylcysteine/paracetamol |
|
1802 | 1 |
p. 15 |
article |
||
| 3 | Afatinib/erlotinib/gefitinib |
|
1802 | 1 |
p. 16 |
article |
||
| 4 | Alcohol |
|
1802 | 1 |
p. 17 |
article |
||
| 5 | Alemtuzumab |
|
1802 | 1 |
p. 21 |
article |
||
| 6 | Alemtuzumab |
|
1802 | 1 |
p. 20 |
article |
||
| 7 | Alemtuzumab |
|
1802 | 1 |
p. 18 |
article |
||
| 8 | Alemtuzumab |
|
1802 | 1 |
p. 24 |
article |
||
| 9 | Alemtuzumab |
|
1802 | 1 |
p. 23 |
article |
||
| 10 | Alemtuzumab |
|
1802 | 1 |
p. 22 |
article |
||
| 11 | Alemtuzumab |
|
1802 | 1 |
p. 19 |
article |
||
| 12 | Alemtuzumab/prednisone |
|
1802 | 1 |
p. 25 |
article |
||
| 13 | Alemtuzumab/teriflunomide |
|
1802 | 1 |
p. 26 |
article |
||
| 14 | Alendronic acid/methylprednisolone/prednisone |
|
1802 | 1 |
p. 27 |
article |
||
| 15 | Allergy-immunotherapies |
|
1802 | 1 |
p. 28 |
article |
||
| 16 | Amino-acids/glucose/lipid-emulsion |
|
1802 | 1 |
p. 29 |
article |
||
| 17 | Amiodarone |
|
1802 | 1 |
p. 30 |
article |
||
| 18 | Amiodarone/dobutamine |
|
1802 | 1 |
p. 31 |
article |
||
| 19 | Amitriptyline/duloxetine interaction |
|
1802 | 1 |
p. 32 |
article |
||
| 20 | Amlodipine/captopril/doxazosin overdose |
|
1802 | 1 |
p. 33 |
article |
||
| 21 | Amoxicillin/clavulanic-acid |
|
1802 | 1 |
p. 34 |
article |
||
| 22 | Amphotericin-B-liposomal |
|
1802 | 1 |
p. 35 |
article |
||
| 23 | Amphotericin-B/methylprednisolone |
|
1802 | 1 |
p. 36 |
article |
||
| 24 | Antibacterials |
|
1802 | 1 |
p. 39 |
article |
||
| 25 | Antibacterials |
|
1802 | 1 |
p. 40 |
article |
||
| 26 | Antibacterials/immunosuppressants/hydrocortisone |
|
1802 | 1 |
p. 41 |
article |
||
| 27 | Anti-CD19-CAR-transduced-T-cells/pembrolizumab |
|
1802 | 1 |
p. 37 |
article |
||
| 28 | Anticoagulants/antiplatelets |
|
1802 | 1 |
p. 42 |
article |
||
| 29 | Antihypertensives/digoxin/rivaroxaban |
|
1802 | 1 |
p. 43 |
article |
||
| 30 | Antimalarial use in COVID-19 patients requires close monitoring |
|
1802 | 1 |
p. 1 |
article |
||
| 31 | Antineoplastics |
|
1802 | 1 |
p. 51 |
article |
||
| 32 | Antineoplastics |
|
1802 | 1 |
p. 47 |
article |
||
| 33 | Antineoplastics |
|
1802 | 1 |
p. 44 |
article |
||
| 34 | Antineoplastics |
|
1802 | 1 |
p. 45 |
article |
||
| 35 | Antineoplastics |
|
1802 | 1 |
p. 50 |
article |
||
| 36 | Antineoplastics |
|
1802 | 1 |
p. 46 |
article |
||
| 37 | Antineoplastics |
|
1802 | 1 |
p. 49 |
article |
||
| 38 | Antineoplastics |
|
1802 | 1 |
p. 48 |
article |
||
| 39 | Antineoplastics/filgrastim |
|
1802 | 1 |
p. 52 |
article |
||
| 40 | Antineoplastics/methylprednisolone |
|
1802 | 1 |
p. 53 |
article |
||
| 41 | Antineoplastics/piperacillin/tazobactam interaction |
|
1802 | 1 |
p. 54 |
article |
||
| 42 | Antiretrovirals |
|
1802 | 1 |
p. 55 |
article |
||
| 43 | Anti-thymocyte globulin |
|
1802 | 1 |
p. 38 |
article |
||
| 44 | Antithymocyte globulin/bortezomib |
|
1802 | 1 |
p. 56 |
article |
||
| 45 | Antituberculars |
|
1802 | 1 |
p. 57 |
article |
||
| 46 | Apixaban |
|
1802 | 1 |
p. 58 |
article |
||
| 47 | Argatroban |
|
1802 | 1 |
p. 59 |
article |
||
| 48 | Arsenic trioxide/interferon alpha/zidovudine |
|
1802 | 1 |
p. 60 |
article |
||
| 49 | Ascorbic acid |
|
1802 | 1 |
p. 61 |
article |
||
| 50 | Aspirin |
|
1802 | 1 |
p. 62 |
article |
||
| 51 | Aspirin use associated with depression |
|
1802 | 1 |
p. 6 |
article |
||
| 52 | Atezolizumab |
|
1802 | 1 |
p. 63 |
article |
||
| 53 | Atezolizumab/nivolumab/pembrolizumab |
|
1802 | 1 |
p. 64 |
article |
||
| 54 | Atorvastatin |
|
1802 | 1 |
p. 65 |
article |
||
| 55 | Atorvastatin |
|
1802 | 1 |
p. 66 |
article |
||
| 56 | Axicabtagene-ciloleucel |
|
1802 | 1 |
p. 67 |
article |
||
| 57 | Axicabtagene-ciloleucel/cyclophosphamide/fludarabine |
|
1802 | 1 |
p. 68 |
article |
||
| 58 | Azathioprine |
|
1802 | 1 |
p. 69 |
article |
||
| 59 | Azathioprine |
|
1802 | 1 |
p. 70 |
article |
||
| 60 | Azathioprine/tioguanine |
|
1802 | 1 |
p. 71 |
article |
||
| 61 | Baclofen |
|
1802 | 1 |
p. 72 |
article |
||
| 62 | BCG-vaccine/prednisolone |
|
1802 | 1 |
p. 73 |
article |
||
| 63 | Bendamustine/cytarabine/rituximab |
|
1802 | 1 |
p. 74 |
article |
||
| 64 | Bendamustine/rituximab |
|
1802 | 1 |
p. 75 |
article |
||
| 65 | Bevacizumab |
|
1802 | 1 |
p. 76 |
article |
||
| 66 | Biapenem/vancomycin |
|
1802 | 1 |
p. 77 |
article |
||
| 67 | Botulinum toxin-A |
|
1802 | 1 |
p. 79 |
article |
||
| 68 | Botulinum toxin-A |
|
1802 | 1 |
p. 78 |
article |
||
| 69 | Brigatinib/crizotinib/lorlatinib |
|
1802 | 1 |
p. 80 |
article |
||
| 70 | Brivaracetam/valproate-semisodium |
|
1802 | 1 |
p. 81 |
article |
||
| 71 | Bupivacaine/paracetamol/ropivacaine |
|
1802 | 1 |
p. 82 |
article |
||
| 72 | Cabazitaxel |
|
1802 | 1 |
p. 83 |
article |
||
| 73 | Calcium carbamide overdose |
|
1802 | 1 |
p. 84 |
article |
||
| 74 | Calcium-gluconate |
|
1802 | 1 |
p. 86 |
article |
||
| 75 | Calcium polystyrene sulfonate |
|
1802 | 1 |
p. 85 |
article |
||
| 76 | Camrelizumab |
|
1802 | 1 |
p. 87 |
article |
||
| 77 | Capecitabine/fluorouracil |
|
1802 | 1 |
p. 88 |
article |
||
| 78 | Captopril/thiamazole/thioctic acid |
|
1802 | 1 |
p. 89 |
article |
||
| 79 | Carbamazepine/haloperidol/lurasidone withdrawal |
|
1802 | 1 |
p. 91 |
article |
||
| 80 | Carbamazepine overdose |
|
1802 | 1 |
p. 90 |
article |
||
| 81 | Carfilzomib |
|
1802 | 1 |
p. 92 |
article |
||
| 82 | Ceftriaxone/dexamethasone |
|
1802 | 1 |
p. 93 |
article |
||
| 83 | Chloroquine/hydroxychloroquine |
|
1802 | 1 |
p. 94 |
article |
||
| 84 | Ciclosporin |
|
1802 | 1 |
p. 95 |
article |
||
| 85 | Ciclosporin |
|
1802 | 1 |
p. 96 |
article |
||
| 86 | Cisplatin/cyclophosphamide/doxorubicin |
|
1802 | 1 |
p. 97 |
article |
||
| 87 | Cisplatin/gemcitabine |
|
1802 | 1 |
p. 98 |
article |
||
| 88 | Citric-acid/magnesium-oxide/sodium-picosulfate |
|
1802 | 1 |
p. 99 |
article |
||
| 89 | Clopidogrel |
|
1802 | 1 |
p. 100 |
article |
||
| 90 | Colchicine overdose |
|
1802 | 1 |
p. 101 |
article |
||
| 91 | Colecalciferol |
|
1802 | 1 |
p. 102 |
article |
||
| 92 | Corticosteroids/rituximab/tacrolimus |
|
1802 | 1 |
p. 103 |
article |
||
| 93 | Cotrimoxazole |
|
1802 | 1 |
p. 104 |
article |
||
| 94 | Cotrimoxazole/dapsone |
|
1802 | 1 |
p. 105 |
article |
||
| 95 | Crizotinib |
|
1802 | 1 |
p. 106 |
article |
||
| 96 | Cyclophosphamide |
|
1802 | 1 |
p. 107 |
article |
||
| 97 | Cyclophosphamide |
|
1802 | 1 |
p. 108 |
article |
||
| 98 | Cyclophosphamide/dexamethasone/venetoclax |
|
1802 | 1 |
p. 109 |
article |
||
| 99 | Cyclophosphamide/doxorubicin/vincristine |
|
1802 | 1 |
p. 110 |
article |
||
| 100 | Cytarabine/daunorubicin/decitabine |
|
1802 | 1 |
p. 111 |
article |
||
| 101 | Cytarabine/daunorubicin/methotrexate |
|
1802 | 1 |
p. 112 |
article |
||
| 102 | Daclatasvir |
|
1802 | 1 |
p. 113 |
article |
||
| 103 | Daratumumab |
|
1802 | 1 |
p. 114 |
article |
||
| 104 | Dexamethasone |
|
1802 | 1 |
p. 116 |
article |
||
| 105 | Dexamethasone |
|
1802 | 1 |
p. 115 |
article |
||
| 106 | Dexamethasone/methotrexate |
|
1802 | 1 |
p. 117 |
article |
||
| 107 | Digoxin |
|
1802 | 1 |
p. 118 |
article |
||
| 108 | Dimethyl-fumarate |
|
1802 | 1 |
p. 119 |
article |
||
| 109 | Dimeticone |
|
1802 | 1 |
p. 120 |
article |
||
| 110 | Dimeticone/hydroxyethyl-methacrylate/polymethyl-methacrylate |
|
1802 | 1 |
p. 121 |
article |
||
| 111 | Docetaxel |
|
1802 | 1 |
p. 123 |
article |
||
| 112 | Docetaxel |
|
1802 | 1 |
p. 122 |
article |
||
| 113 | Doxorubicin-liposomal |
|
1802 | 1 |
p. 124 |
article |
||
| 114 | Duloxetine |
|
1802 | 1 |
p. 125 |
article |
||
| 115 | Durvalumab |
|
1802 | 1 |
p. 126 |
article |
||
| 116 | Eculizumab |
|
1802 | 1 |
p. 127 |
article |
||
| 117 | Elbasvir/grazoprevir |
|
1802 | 1 |
p. 128 |
article |
||
| 118 | Eltrombopag |
|
1802 | 1 |
p. 129 |
article |
||
| 119 | Eltrombopag |
|
1802 | 1 |
p. 130 |
article |
||
| 120 | EMA: risks of ingenol mebutate use outweigh its benefits |
|
1802 | 1 |
p. 2 |
article |
||
| 121 | Enzalutamide |
|
1802 | 1 |
p. 131 |
article |
||
| 122 | Ephedrine/unspecified crystalloid |
|
1802 | 1 |
p. 132 |
article |
||
| 123 | Epoetin-alfa/zidovudine |
|
1802 | 1 |
p. 133 |
article |
||
| 124 | Eribulin |
|
1802 | 1 |
p. 134 |
article |
||
| 125 | Ezetimibe |
|
1802 | 1 |
p. 135 |
article |
||
| 126 | Factor-VIII/sirolimus |
|
1802 | 1 |
p. 136 |
article |
||
| 127 | Fingolimod |
|
1802 | 1 |
p. 137 |
article |
||
| 128 | Fingolimod |
|
1802 | 1 |
p. 139 |
article |
||
| 129 | Fingolimod |
|
1802 | 1 |
p. 138 |
article |
||
| 130 | Fingolimod/ocrelizumab |
|
1802 | 1 |
p. 141 |
article |
||
| 131 | Fingolimod withdrawal |
|
1802 | 1 |
p. 140 |
article |
||
| 132 | Flecainide |
|
1802 | 1 |
p. 142 |
article |
||
| 133 | Fluconazole |
|
1802 | 1 |
p. 143 |
article |
||
| 134 | Fludarabine/melphalan |
|
1802 | 1 |
p. 144 |
article |
||
| 135 | Fluorouracil |
|
1802 | 1 |
p. 145 |
article |
||
| 136 | Gemcitabine |
|
1802 | 1 |
p. 146 |
article |
||
| 137 | Gimeracil/oteracil/tegafur/rivoceranib |
|
1802 | 1 |
p. 147 |
article |
||
| 138 | Haloperidol/risperidone |
|
1802 | 1 |
p. 148 |
article |
||
| 139 | Health Canada: thiamazole linked with risk of vasculitis |
|
1802 | 1 |
p. 3 |
article |
||
| 140 | High incidence of ADRs in COVID-19 patients in China |
|
1802 | 1 |
p. 7 |
article |
||
| 141 | Imatinib/lansoprazole/rebamipide |
|
1802 | 1 |
p. 149 |
article |
||
| 142 | Immune-globulin/methylprednisolone |
|
1802 | 1 |
p. 150 |
article |
||
| 143 | Immunosuppressants |
|
1802 | 1 |
p. 154 |
article |
||
| 144 | Immunosuppressants |
|
1802 | 1 |
p. 156 |
article |
||
| 145 | Immunosuppressants |
|
1802 | 1 |
p. 152 |
article |
||
| 146 | Immunosuppressants |
|
1802 | 1 |
p. 157-158 |
article |
||
| 147 | Immunosuppressants |
|
1802 | 1 |
p. 155 |
article |
||
| 148 | Immunosuppressants |
|
1802 | 1 |
p. 151 |
article |
||
| 149 | Immunosuppressants |
|
1802 | 1 |
p. 153 |
article |
||
| 150 | Immunosuppressants/tamoxifen |
|
1802 | 1 |
p. 158 |
article |
||
| 151 | Immunosuppressants/voriconazole |
|
1802 | 1 |
p. 159 |
article |
||
| 152 | Infliximab |
|
1802 | 1 |
p. 160 |
article |
||
| 153 | Infliximab |
|
1802 | 1 |
p. 161 |
article |
||
| 154 | Infliximab/interferon-alpha-2a |
|
1802 | 1 |
p. 162 |
article |
||
| 155 | Infliximab/prednisone/vedolizumab |
|
1802 | 1 |
p. 163 |
article |
||
| 156 | Insulin abuse |
|
1802 | 1 |
p. 164 |
article |
||
| 157 | Interferon-alpha-2a |
|
1802 | 1 |
p. 166 |
article |
||
| 158 | Interferon-β-1a/teriflunomide |
|
1802 | 1 |
p. 165 |
article |
||
| 159 | Iodine/measles-mumps-and-rubella-virus-vaccine |
|
1802 | 1 |
p. 167 |
article |
||
| 160 | Iohexol |
|
1802 | 1 |
p. 168 |
article |
||
| 161 | Ipilimumab |
|
1802 | 1 |
p. 169 |
article |
||
| 162 | Ipilimumab/nivolumab |
|
1802 | 1 |
p. 172 |
article |
||
| 163 | Ipilimumab/nivolumab |
|
1802 | 1 |
p. 171 |
article |
||
| 164 | Ipilimumab/nivolumab |
|
1802 | 1 |
p. 170 |
article |
||
| 165 | Ipilimumab/pembrolizumab |
|
1802 | 1 |
p. 173 |
article |
||
| 166 | Isoniazid/streptomycin |
|
1802 | 1 |
p. 174 |
article |
||
| 167 | Isoprenaline |
|
1802 | 1 |
p. 175 |
article |
||
| 168 | Isotretinoin |
|
1802 | 1 |
p. 177 |
article |
||
| 169 | Isotretinoin |
|
1802 | 1 |
p. 176 |
article |
||
| 170 | Ketamine |
|
1802 | 1 |
p. 178 |
article |
||
| 171 | Label discrepancies between originator and generic drugs impact safety |
|
1802 | 1 |
p. 8 |
article |
||
| 172 | Lamotrigine |
|
1802 | 1 |
p. 179 |
article |
||
| 173 | Leflunomide/teriflunomide |
|
1802 | 1 |
p. 180 |
article |
||
| 174 | Levodopa/benserazide |
|
1802 | 1 |
p. 181 |
article |
||
| 175 | Levodopa/carbidopa/levodopa/carbidopa/entacapone |
|
1802 | 1 |
p. 182 |
article |
||
| 176 | Lithium |
|
1802 | 1 |
p. 183 |
article |
||
| 177 | Maltose |
|
1802 | 1 |
p. 184 |
article |
||
| 178 | Medi-3250 |
|
1802 | 1 |
p. 185 |
article |
||
| 179 | Metformin |
|
1802 | 1 |
p. 186 |
article |
||
| 180 | Methotrexate |
|
1802 | 1 |
p. 188 |
article |
||
| 181 | Methotrexate |
|
1802 | 1 |
p. 187 |
article |
||
| 182 | Methylprednisolone |
|
1802 | 1 |
p. 191 |
article |
||
| 183 | Methylprednisolone |
|
1802 | 1 |
p. 189 |
article |
||
| 184 | Methylprednisolone |
|
1802 | 1 |
p. 190 |
article |
||
| 185 | Methylprednisolone-acetate |
|
1802 | 1 |
p. 192 |
article |
||
| 186 | Methylprednisolone/metronidazole/secukinumab |
|
1802 | 1 |
p. 193 |
article |
||
| 187 | Midazolam/morphine |
|
1802 | 1 |
p. 194 |
article |
||
| 188 | Multiple drugs |
|
1802 | 1 |
p. 199 |
article |
||
| 189 | Multiple drugs |
|
1802 | 1 |
p. 196 |
article |
||
| 190 | Multiple drugs |
|
1802 | 1 |
p. 202 |
article |
||
| 191 | Multiple drugs |
|
1802 | 1 |
p. 205 |
article |
||
| 192 | Multiple drugs |
|
1802 | 1 |
p. 207 |
article |
||
| 193 | Multiple drugs |
|
1802 | 1 |
p. 201 |
article |
||
| 194 | Multiple drugs |
|
1802 | 1 |
p. 204 |
article |
||
| 195 | Multiple drugs |
|
1802 | 1 |
p. 203 |
article |
||
| 196 | Multiple drugs |
|
1802 | 1 |
p. 197 |
article |
||
| 197 | Multiple drugs |
|
1802 | 1 |
p. 200 |
article |
||
| 198 | Multiple drugs |
|
1802 | 1 |
p. 198 |
article |
||
| 199 | Multiple drugs |
|
1802 | 1 |
p. 206 |
article |
||
| 200 | Multiple drugs |
|
1802 | 1 |
p. 195 |
article |
||
| 201 | Mycophenolate-mofetil |
|
1802 | 1 |
p. 211 |
article |
||
| 202 | Mycophenolate mofetil/prednisolone/tacrolimus |
|
1802 | 1 |
p. 208 |
article |
||
| 203 | Mycophenolate mofetil/prednisone/sirolimus |
|
1802 | 1 |
p. 209 |
article |
||
| 204 | Mycophenolate mofetil/prednisone/tacrolimus |
|
1802 | 1 |
p. 210 |
article |
||
| 205 | Mycophenolate/prednisone/tacrolimus |
|
1802 | 1 |
p. 213 |
article |
||
| 206 | Mycophenolate/prednisone/tacrolimus |
|
1802 | 1 |
p. 212 |
article |
||
| 207 | Mycophenolic-acid/prednisone/tacrolimus |
|
1802 | 1 |
p. 214 |
article |
||
| 208 | Nadolol |
|
1802 | 1 |
p. 215 |
article |
||
| 209 | Natalizumab |
|
1802 | 1 |
p. 216 |
article |
||
| 210 | Natalizumab |
|
1802 | 1 |
p. 217 |
article |
||
| 211 | Need to improve pharmacovigilance of herbal and traditional medicines |
|
1802 | 1 |
p. 4 |
article |
||
| 212 | Neurological disorders after in utero exposure to antiretrovirals |
|
1802 | 1 |
p. 9 |
article |
||
| 213 | Nitroglycerin |
|
1802 | 1 |
p. 218 |
article |
||
| 214 | Nivolumab |
|
1802 | 1 |
p. 222 |
article |
||
| 215 | Nivolumab |
|
1802 | 1 |
p. 221 |
article |
||
| 216 | Nivolumab |
|
1802 | 1 |
p. 220 |
article |
||
| 217 | Nivolumab |
|
1802 | 1 |
p. 223 |
article |
||
| 218 | Nivolumab |
|
1802 | 1 |
p. 219 |
article |
||
| 219 | Nivolumab/pembrolizumab |
|
1802 | 1 |
p. 224 |
article |
||
| 220 | Nivolumab/pembrolizumab |
|
1802 | 1 |
p. 225 |
article |
||
| 221 | Nivolumab/prednisone |
|
1802 | 1 |
p. 226 |
article |
||
| 222 | Non-serious case reports |
|
1802 | 1 |
p. 276-277 |
article |
||
| 223 | Nusinersen |
|
1802 | 1 |
p. 227 |
article |
||
| 224 | Ocrelizumab |
|
1802 | 1 |
p. 229 |
article |
||
| 225 | Ocrelizumab |
|
1802 | 1 |
p. 228 |
article |
||
| 226 | Opioid-analgesics |
|
1802 | 1 |
p. 230 |
article |
||
| 227 | Osimertinib |
|
1802 | 1 |
p. 231 |
article |
||
| 228 | Osimertinib |
|
1802 | 1 |
p. 232 |
article |
||
| 229 | Other adverse reaction research |
|
1802 | 1 |
p. 14 |
article |
||
| 230 | Oxaliplatin/topotecan/vincristine |
|
1802 | 1 |
p. 233 |
article |
||
| 231 | Oxycodone |
|
1802 | 1 |
p. 234 |
article |
||
| 232 | Paclitaxel |
|
1802 | 1 |
p. 235 |
article |
||
| 233 | Paracetamol |
|
1802 | 1 |
p. 236 |
article |
||
| 234 | Paracetamol/caffeine/salicylamide/promethazine |
|
1802 | 1 |
p. 237 |
article |
||
| 235 | Pazopanib |
|
1802 | 1 |
p. 238 |
article |
||
| 236 | Pembrolizumab |
|
1802 | 1 |
p. 242 |
article |
||
| 237 | Pembrolizumab |
|
1802 | 1 |
p. 240 |
article |
||
| 238 | Pembrolizumab |
|
1802 | 1 |
p. 239 |
article |
||
| 239 | Pembrolizumab |
|
1802 | 1 |
p. 241 |
article |
||
| 240 | Pentostatin |
|
1802 | 1 |
p. 243 |
article |
||
| 241 | Permethrin |
|
1802 | 1 |
p. 244 |
article |
||
| 242 | Phenytoin overdose |
|
1802 | 1 |
p. 245 |
article |
||
| 243 | Plasma |
|
1802 | 1 |
p. 246 |
article |
||
| 244 | Pneumococcal-vaccine |
|
1802 | 1 |
p. 247 |
article |
||
| 245 | Praziquantel/prednisolone interaction |
|
1802 | 1 |
p. 248 |
article |
||
| 246 | Prednisolone acetate |
|
1802 | 1 |
p. 249 |
article |
||
| 247 | Prednisone |
|
1802 | 1 |
p. 250 |
article |
||
| 248 | Prednisone/tacrolimus |
|
1802 | 1 |
p. 251 |
article |
||
| 249 | Renal failure increases risk of anticoagulant-related haemorrhage |
|
1802 | 1 |
p. 10 |
article |
||
| 250 | Riluzole |
|
1802 | 1 |
p. 252 |
article |
||
| 251 | Risperidone/trazodone |
|
1802 | 1 |
p. 253 |
article |
||
| 252 | Risperidone/venlafaxine |
|
1802 | 1 |
p. 254 |
article |
||
| 253 | Rituximab |
|
1802 | 1 |
p. 256 |
article |
||
| 254 | Rituximab |
|
1802 | 1 |
p. 257 |
article |
||
| 255 | Rituximab |
|
1802 | 1 |
p. 255 |
article |
||
| 256 | Rivaroxaban |
|
1802 | 1 |
p. 258 |
article |
||
| 257 | Ruxolitinib |
|
1802 | 1 |
p. 259 |
article |
||
| 258 | Ruxolitinib |
|
1802 | 1 |
p. 260 |
article |
||
| 259 | Safety concerns with higher dosage chloroquine in COVID-19 patients |
|
1802 | 1 |
p. 11 |
article |
||
| 260 | Secukinumab |
|
1802 | 1 |
p. 261 |
article |
||
| 261 | Shishihakuhito |
|
1802 | 1 |
p. 262 |
article |
||
| 262 | Sildenafil overdose |
|
1802 | 1 |
p. 263 |
article |
||
| 263 | Simeprevir/sofosbuvir |
|
1802 | 1 |
p. 264 |
article |
||
| 264 | Suboptimal agreement between clinician and patient reporting of AEs |
|
1802 | 1 |
p. 12 |
article |
||
| 265 | Suxamethonium-chloride |
|
1802 | 1 |
p. 265 |
article |
||
| 266 | Tacrolimus |
|
1802 | 1 |
p. 268 |
article |
||
| 267 | Tacrolimus |
|
1802 | 1 |
p. 266 |
article |
||
| 268 | Tacrolimus |
|
1802 | 1 |
p. 267 |
article |
||
| 269 | Tacrolimus |
|
1802 | 1 |
p. 269 |
article |
||
| 270 | Tamoxifen |
|
1802 | 1 |
p. 270 |
article |
||
| 271 | Tedizolid has better tolerability than linezolid |
|
1802 | 1 |
p. 13 |
article |
||
| 272 | Ticagrelor |
|
1802 | 1 |
p. 271 |
article |
||
| 273 | Valproic acid overdose |
|
1802 | 1 |
p. 272 |
article |
||
| 274 | Voriconazole |
|
1802 | 1 |
p. 273 |
article |
||
| 275 | Voriconazole |
|
1802 | 1 |
p. 274 |
article |
||
| 276 | Warfarin |
|
1802 | 1 |
p. 275 |
article |
276 results found